Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for GHRS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2021. Start Trial.
Date Value
June 30, 2026 362.65M
March 31, 2026 267.32M
December 31, 2025 280.71M
September 30, 2025 288.51M
June 30, 2025 291.54M
March 31, 2025 291.35M
December 31, 2024 149.32M
September 30, 2024 150.04M
June 30, 2024 151.32M
March 31, 2024 157.86M
December 31, 2023 161.56M
Date Value
September 30, 2023 161.28M
June 30, 2023 165.38M
March 31, 2023 162.82M
December 31, 2022 165.96M
September 30, 2022 256.94M
June 30, 2022 265.38M
March 31, 2022 270.75M
December 31, 2021 276.78M
September 30, 2021 280.74M
June 30, 2021 292.62M
March 31, 2021 4.576M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Atai Beckley, Inc. 225.81M
Avadel Pharmaceuticals Plc 91.58M
Jazz Pharmaceuticals Plc 2.200B
Eli Lilly & Co. 8.95B
Perrigo Co. Plc 399.70M